These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20036942)

  • 1. Novel therapeutic approaches in systemic lupus erythematosus.
    Kiss E; Szodoray P
    Front Biosci (Schol Ed); 2010 Jan; 2(1):221-8. PubMed ID: 20036942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel therapeutic possibilities in systemic lupus erythematosus].
    Bazsó A; Poór G; Gergely P; Kiss E
    Orv Hetil; 2010 May; 151(18):735-40. PubMed ID: 20410000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-based therapies in systemic lupus erythematosus.
    Iikuni N; La Cava A
    Mini Rev Med Chem; 2009 Jun; 9(7):829-46. PubMed ID: 19519508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.
    Yap DYH; Chan TM
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells.
    Looney RJ; Anolik J; Sanz I
    Lupus; 2004; 13(5):381-90. PubMed ID: 15230297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances and current state of immunotherapy in systemic lupus erythematosus.
    Mok MY; Shoenfeld Y
    Expert Opin Biol Ther; 2016 Jul; 16(7):927-39. PubMed ID: 27032059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does B cell depletion have a role to play in the treatment of systemic lupus erythematosus?
    Gorman C; Leandro M; Isenberg D
    Lupus; 2004; 13(5):312-6. PubMed ID: 15230284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLE - Rituximab in lupus.
    Eisenberg R
    Arthritis Res Ther; 2003; 5(4):157-9. PubMed ID: 12823844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
    Harvey PR; Gordon C
    BioDrugs; 2013 Apr; 27(2):85-95. PubMed ID: 23456653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of inflammatory immunologic disease 4. B cell targeting therapy using the anti-CD20 antibody rituximab in inflammatory autoimmune diseases.
    Tanaka Y
    Intern Med; 2007; 46(16):1313-5. PubMed ID: 17704614
    [No Abstract]   [Full Text] [Related]  

  • 11. B cells in SLE: different biological drugs for different pathogenic mechanisms.
    Diamanti AP; Rosado MM; Carsetti R; Valesini G
    Autoimmun Rev; 2007 Dec; 7(2):143-8. PubMed ID: 18035325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell biology and related therapies in systemic lupus erythematosus.
    Ahmed S; Anolik JH
    Rheum Dis Clin North Am; 2010 Feb; 36(1):109-30, viii-ix. PubMed ID: 20202594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell targeted treatments for lupus: the journey counts as much as the destination.
    Falgarone G; Dhote R; Boissier MC
    Joint Bone Spine; 2012 Oct; 79(5):437-40. PubMed ID: 22480746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of systemic lupus erythematosus.
    Francis L; Perl A
    Expert Opin Pharmacother; 2009 Jun; 10(9):1481-94. PubMed ID: 19505215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic changes of lymphocytes in patients with systemic lupus erythematosus who are in longterm remission after B cell depletion therapy with rituximab.
    Iwata S; Saito K; Tokunaga M; Yamaoka K; Nawata M; Yukawa S; Hanami K; Fukuyo S; Miyagawa I; Kubo S; Tanaka Y
    J Rheumatol; 2011 Apr; 38(4):633-41. PubMed ID: 21159836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus.
    Yu SL; Kuan WP; Wong CK; Li EK; Tam LS
    Clin Dev Immunol; 2012; 2012():715190. PubMed ID: 22312407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future.
    Jacob N; Stohl W
    Autoimmunity; 2010 Feb; 43(1):84-97. PubMed ID: 20014977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells targeting therapy in the management of systemic lupus erythematosus.
    Lee WS; Amengual O
    Immunol Med; 2020 Mar; 43(1):16-35. PubMed ID: 32107989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies.
    Fattah Z; Isenberg DA
    Expert Opin Biol Ther; 2014 Mar; 14(3):311-26. PubMed ID: 24387632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.